MARKET

PCVX

PCVX

Vaxcyte, Inc.
NASDAQ
60.67
+0.70
+1.17%
Pre Market: 60.65 -0.02 -0.03% 08:56 10/28 EDT
OPEN
59.92
PREV CLOSE
59.97
HIGH
61.30
LOW
59.43
VOLUME
100
TURNOVER
0
52 WEEK HIGH
90.75
52 WEEK LOW
39.87
MARKET CAP
9.03B
P/E (TTM)
-7.9459
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at PCVX last week (1019-1023)?
Weekly Report · 2d ago
Vaxcyte (PCVX) Receives a Buy from Guggenheim
TipRanks · 10/19 16:06
Vaxcyte: Vaccine Titan In The Making
Seeking Alpha · 10/19 11:30
Weekly Report: what happened at PCVX last week (1012-1016)?
Weekly Report · 10/19 09:17
Show Me The Money: Vaxcyte Delivers 100%+ Gains As Pneumococcal Vaccine Program Advances
NASDAQ · 10/16 09:02
Vaxcyte (PCVX), What Is Behind The Fresh Attention?
Simply Wall St · 10/15 14:31
Wall Street Analysts Think Vaxcyte (PCVX) Could Surge 75.6%: Read This Before Placing a Bet
NASDAQ · 10/14 12:55
Vaxcyte Stock In Focus After Phase 3 Vaccine Trial Success
Simply Wall St · 10/14 12:23
More
About PCVX
Vaxcyte, Inc. is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. The Company's pipeline includes VAX-31, VAX-24 and VAX-XL. VAX-31, a 31-valent PCV candidate being evaluated in the OPUS Phase III adult clinical program and in a Phase II infant clinical program, is being developed for the prevention of IPD and is the broadest-spectrum PCV candidate in the clinic today. VAX-24, a 24-valent PCV candidate, is designed to cover more serotypes than any infant PCV on-market. VAX-XL leverages the Company’s carrier-sparing, site-specific conjugation technology. It is re-engineering the way highly complex vaccines are made through XpressCF, its cell-free protein synthesis platform exclusively licensed from Sutro Biopharma, Inc. Its pipeline also includes VAX-A1, a prophylactic vaccine candidate designed to prevent Group A Strep infections, and VAX-GI, a vaccine candidate designed to prevent Shigella.

Webull offers Vaxcyte Inc stock information, including NASDAQ: PCVX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PCVX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PCVX stock methods without spending real money on the virtual paper trading platform.